GeneOne Life Science, Inc. (KRX:011000)
South Korea · Delayed Price · Currency is KRW
1,202.00
-19.00 (-1.56%)
Last updated: Feb 26, 2026, 11:51 AM KST
Revenue by Segment
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
|---|
| 13.29B | 12.75B | 15.88B | 14.34B | 13.54B | | | | | |
| 4.27% | -19.71% | 10.70% | 5.94% | -18.82% | | | | | |
| 22.43B | 27.45B | 32.84B | 24.36B | 27.96B | | | | | |
Pharmaceutical Business Growth | -18.31% | -16.40% | 34.83% | -12.90% | 13.85% | | | | | |
| 35.72B | 40.20B | 48.72B | 38.70B | 41.50B | | | | | |
| -11.15% | -17.48% | 25.89% | -6.75% | 0.63% | | | | | |
Revenue by Geography
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
|---|
| 2.10B | 4.12B | 4.54B | 3.29B | 2.79B | | | | | |
| -48.97% | -9.29% | 38.00% | 17.83% | -22.35% | | | | | |
| 33.62B | 36.09B | 44.18B | 35.41B | 38.71B | | | | | |
| -6.84% | -18.32% | 24.76% | -8.52% | 2.83% | | | | | |
| 35.72B | 40.20B | 48.72B | 38.70B | 41.50B | | | | | |
| -11.15% | -17.48% | 25.89% | -6.75% | 0.63% | | | | | |
Source: S&P Global Market Intelligence.